EQS Group-Ad-hoc: Medacta Group SA / Key word(s): Regulatory Approval
Medacta Group SA receives approval in Japan for MyShoulder Placement Guides
24-Jul-2019 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
*Press Release
Medacta receives approval in Japan for MyShoulder Placement Guides*
_Castel San Pietro, 24 July 2019_ - Medacta International will soon
introduce the MyShoulder Placement Guides for shoulder arthroplasty in the
Japanese market after it has successfully obtained the Pharmaceutical and
Medical Device Agency (PMDA) approval.
After the recent launch of its shoulder implants in Japan, Medacta is
further expanding the shoulder product offerings with the MyShoulder
Placement Guides.
These patient-specific, 3D-printed solutions work in conjunction with the
Medacta Shoulder System and associated instrumentation to create a precise
surgical approach specific to each patient's individual anatomy. It is
composed by two guides and a WebPlanner. The two guides, a humeral cutting
guide and a glenoidal reaming guide, assist the surgeon optimizing the
accuracy and reducing the surgery time. The WebPlanner allows the surgeon to
carry out a precise preoperative planning.
The MyShoulder platform is part of the sophisticated "MySolutions"
technology. Thanks to the creation of advanced personalized kinematic models
and 3D planning tools, MySolutions are highly personalized pre-operative
planning and implant placement methodologies for use not only in shoulder
procedures, but also in hip (MyHip), knee (MyKnee) and spine (MySpine)
procedures.
"The development of highly patient-personalized pre-operative planning and
implant placement methodologies using our MySolutions technology has been
one of our key innovations" said Francesco Siccardi, CEO of Medacta
International. "The introduction of the MyShoulder system is an important
step to further expand our activities in the Japanese market."
For more information, please visit the MyShoulder webpage at
https://www.medacta.com/EN/medacta-shoulder-system-global [1].
*Inquiries*
Corrado Farsetta
Medacta Group SA
CFO
Phone: +41 91 696 60 60
investor.relations@medacta.ch
*About Medacta *
Medacta is an international orthopaedics company specializing in the design
and production of innovative orthopaedic products and the development of
accompanying surgical techniques. Established in 1999 in Switzerland,
Medacta's products and surgical techniques are characterized by innovation.
Medacta is a pioneer in developing new offerings on the basis of the
minimally invasive surgical techniques, in particular its Anterior Minimally
Invasive Surgery ("AMIS") technique for hip replacements. Medacta has
leveraged its orthopedic expertise and comprehensive understanding of the
human body to develop the sophisticated "MySolutions" technology, which
offers surgeons highly personalized pre-operative planning and implant
placement methodologies by creating advanced personalized kinematic models
and 3D planning tools for use in hip, knee, shoulder and spine procedures.
Medacta is headquartered in Castel San Pietro, Switzerland, and employs
approximately 970 people. To learn more about Medacta, please visit
www.medacta.com
End of ad hoc announcement
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 696 6060
E-mail: info@medacta.ch, investor.relations@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 845581
End of Announcement EQS Group News Service
845581 24-Jul-2019 CET/CEST
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=478c6727e8966d97c644857e1e03725d&application_id=845581&site_id=vwd&application_name=news
(END) Dow Jones Newswires
July 24, 2019 01:00 ET (05:00 GMT)
